CY1112087T1 - Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα - Google Patents

Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα

Info

Publication number
CY1112087T1
CY1112087T1 CY20111101154T CY111101154T CY1112087T1 CY 1112087 T1 CY1112087 T1 CY 1112087T1 CY 20111101154 T CY20111101154 T CY 20111101154T CY 111101154 T CY111101154 T CY 111101154T CY 1112087 T1 CY1112087 T1 CY 1112087T1
Authority
CY
Cyprus
Prior art keywords
products
rythromycin
procedure
application
new
Prior art date
Application number
CY20111101154T
Other languages
English (en)
Inventor
Alexis Denis
Giuseppe Gigliotti
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9808795A external-priority patent/FR2780977B1/fr
Priority claimed from FR9905245A external-priority patent/FR2792637B1/fr
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of CY1112087T1 publication Critical patent/CY1112087T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Η εφεύρεση έχει ως αντικείμενο τις ενώσεις του τύπου (Ι)
CY20111101154T 1998-07-09 2011-11-24 Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα CY1112087T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9808795A FR2780977B1 (fr) 1998-07-09 1998-07-09 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR9905245A FR2792637B1 (fr) 1999-04-26 1999-04-26 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP99401706A EP0974598B1 (fr) 1998-07-09 1999-07-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments

Publications (1)

Publication Number Publication Date
CY1112087T1 true CY1112087T1 (el) 2015-11-04

Family

ID=26234434

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111101154T CY1112087T1 (el) 1998-07-09 2011-11-24 Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα

Country Status (8)

Country Link
US (1) US6433151B1 (el)
EP (1) EP0974598B1 (el)
JP (1) JP4573925B2 (el)
AT (1) ATE521619T1 (el)
CY (1) CY1112087T1 (el)
DK (1) DK0974598T3 (el)
ES (1) ES2372156T3 (el)
PT (1) PT974598E (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1137654A1 (en) * 1998-12-10 2001-10-04 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
WO2006080954A1 (en) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2006035301A2 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Erythromycin a derivatives as antibacterial agents
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
PT1836211E (pt) * 2004-12-21 2010-04-08 Pfizer Prod Inc Macrólidos
WO2007054904A2 (en) * 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Macrolides as anti-inflammatory agents
WO2007060518A2 (en) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
US20090130225A1 (en) * 2005-11-23 2009-05-21 Anjan Chakrabarti Macrolides derivatives as antibacterial agents
US20090075916A1 (en) * 2005-11-23 2009-03-19 Upadhyay Dilip J Use of Macrolide Derivatives for Treating Acne
DK2102226T3 (da) * 2006-12-12 2012-12-10 Zambon Spa Makrolidforbindelser med inflammationshæmmende virkning
BR112021011963A2 (pt) * 2018-12-17 2021-09-08 Lunella Biotech, Inc. Terapias de combinação tripla para alvejamento de mitocôndria e exterminação de células-tronco de câncer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725385A (en) * 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
ES2218604T3 (es) 1995-11-08 2004-11-16 Abbott Laboratories Derivados triciclicos de eritromicina.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745290B1 (fr) * 1996-02-28 1998-04-03 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
KR100523679B1 (ko) * 1996-09-04 2005-10-26 아보트 러보러터리즈 항균 활성을 지닌 6-o-치환된 케톨라이드
SK4562000A3 (en) * 1997-09-30 2000-09-12 Abbott Lab 3'-N-MODIFIED 6-O-SUBSTITUTED ERYTHROMYCIN KETOLIDE DERIVATIVESì (54) HAVING ANTIBACTERIAL ACTIVITY

Also Published As

Publication number Publication date
EP0974598A2 (fr) 2000-01-26
PT974598E (pt) 2011-11-23
JP4573925B2 (ja) 2010-11-04
ES2372156T3 (es) 2012-01-16
DK0974598T3 (da) 2011-12-19
EP0974598A3 (fr) 2003-12-17
ATE521619T1 (de) 2011-09-15
US6433151B1 (en) 2002-08-13
EP0974598B1 (fr) 2011-08-24
JP2000026494A (ja) 2000-01-25

Similar Documents

Publication Publication Date Title
CY1112087T1 (el) Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα
ES2085130T3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion, y su aplicacion como medicamentos.
FR2518088B1 (fr) Nouveaux derives d'aminoacides, et leur application therapeutique
TR199902593T2 (xx) �kame edilmi� fenil t�revleri, bunlar�n haz�rlanmas� ve kullan�m�.
YU37098A (sh) Novi derivati eritromicina, postupci za njihovo pripremanje i njihova primena kao medikamenata
CY1112274T1 (el) Νεοι ολιγοσακχαριτες, η παρασκευh τους και οι φαρμακευτικες συνθεσεις οι οποιες τους περιεχουν
TR199501253A2 (tr) Amino(tio) eter türevleri.
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
YU13396A (sh) N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima
SE8502017D0 (sv) 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
EA200100983A1 (ru) Производные 13-метилэритромицина
DE69320339D1 (de) Derivate des Dolastatin
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
HUP9903459A2 (hu) Oxa- és tiabiciklo[3.1.0]hexán-karbonsavak, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
CY1106396T1 (el) Γραμμικες ή κυκλικες ουριες, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις οι οποιες τις πepιεχουν
BRPI0210746B8 (pt) derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina e seu método de preparação
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
DE69126758D1 (de) Benzamid-Derivate
FI911189A0 (fi) Nya ureaderivat och deras salter, dessa innehaollande farmaceutiska blandningar och foerfarande foer deras framstaellning.
ES2058849T3 (es) Benzanilidas.
ECSP941031A (es) Derivados de timosina alfa 1
SE8303913L (sv) Heterocykliska foreningar
EE02942B1 (et) Metüülpiperasinoasepiini derivaadid, nende valmistamine ja kasutamine
DK0541322T3 (da) 1-Alkyl-2-acyl-1,2-disulfonylhydraziner med antineoplastisk aktivitet